Mark A Rettenmaier

10PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markersPreventative health careMolecular targetsChemotherapyTime-series analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 18, 2025
Clinical differences among the PARP inhibitors in the first-line treatment of advanced-stage ovarian carcinoma.

John P Micha, Mark A Rettenmaier, Randy Bohart

|Mar 24, 2025
A review of sunscreen in the prevention of skin cancer.

John P Micha, Randy D Bohart, Bram H Goldstein

|Nov 05, 2024
Statin use and ovarian cancer outcomes.

John P Micha, Mark A Rettenmaier, Randy D Bohart

|Jun 20, 2024
Medical marijuana in the treatment of cancer-associated symptoms.

John P Micha, Mark A Rettenmaier, Randy D Bohart

|Feb 26, 2024
Cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer.

John P Micha, Mark A Rettenmaier, Randy D Bohart

|Apr 06, 2023
Reply to the letter to the editor: a response to Tran and Egilman.

John P Micha, Mark A Rettenmaier, Randy D Bohart

Pageof 2